Printer Friendly
The Free Library
4,488,576 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Genentech Among Wall Street's Movers


Stocks that were moving substantially or trading heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market:

NYSE

Genentech Inc., down $1.69 at $81.

The biotechnology company said first-quarter sales of its two key cancer treatments fell from the fourth quarter. The company's first-quarter profit surged 68 percent.

Manor Care Inc., up $1.33 at $63.01.

The company said Wednesday it is considering its options, including a sale assets or the entire company.

NovaStar Financial Inc., up 26 cents at $5.29.

The mortgage lender, which has struggled with its portfolio of so-called subprime mortgages, said it is considering putting itself up for sale.

NASDAQ

Research in Motion Ltd., down $11.55 at $134.47.

The maker of the BlackBerry handheld device disclosed that the Securities and Exchange Commission has formalized an investigation into the company's practices for granting stock options. The company said its fiscal fourth-quarter sales jumped 66 percent.

Bare Escentuals Inc., up 64 cents at $38.24.

A Goldman Sachs analyst raised her rating on shares of the natural cosmetics maker, citing growth opportunities, including market-share gains and sales of skin-care products.

ECtel Ltd., down $1.32 at $3.22.

The provider of fraud-prevention software warned sales have been hurt in part by slower-than-expected orders. The company expects first-quarter revenue of $3.4 million to $3.6 million; revenue totaled $6.7 million in the first quarter last year.

Copyright 2007 AP News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright (c) Mochila, Inc.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Staff
Publication:AP News
Date:Apr 12, 2007
Words:224
Previous Article:Sherpas aim for Everest record
Next Article:Senate blocks Medicare drug price bill



Related Articles
Genentech 1Q profit up 68 pct. to $706M
Genentech 1Q profit up 68 pct. to $706M
Genentech among Wall Street's movers
Genentech among Wall Street's movers
Drug may help lung cancer patients
Genentech 3Q profit increases 21 percent
Genentech 3Q profit increases 21 percent
Genentech 4Q profit rises 6 percent
Genentech 4Q profit rises 6 percent

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles